Related Experiment Video
Updated: Nov 27, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway
Shi-Jia Yu1, Ming-Jun Yu2, Zhong-Qi Bu1
1Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Abstract:
Apoptosis is an important programmed cell death process involved in ischemia/reperfusion injury. MicroRNAs are considered to play an important role in the molecular mechanism underlying the regulation of cerebral ischemia and reperfusion injury. However, whether miR-670 can regulate cell growth and death in cerebral ischemia/reperfusion and the underlying mechanism are poorly understood. In this study, we established mouse models of transient middle artery occlusion and Neuro 2a cell models of oxygen-glucose deprivation and reoxygenation to investigate the potential molecular mechanism by which miR-670 exhibits its effects during cerebral ischemia/reperfusion injury both in vitro and in vivo. Our results showed that after ischemia/reperfusion injury, miR-670 expression was obviously increased. After miR-670 expression was inhibited with an miR-670 antagomir, cerebral ischemia/reperfusion injury-induced neuronal death was obviously reduced. When miR-670 overexpression was induced by an miR-670 agomir, neuronal apoptosis was increased. In addition, we also found that miR-670 could promote Yap degradation via phosphorylation and worsen neuronal apoptosis and neurological deficits. Inhibition of miR-670 reduced neurological impairments after cerebral ischemia/reperfusion injury. These results suggest that microRNA-670 aggravates cerebral ischemia/reperfusion injury through the Yap pathway, which may be a potential target for treatment of cerebral ischemia/reperfusion injury. The present study was approved by the Institutional Animal Care and Use Committee of China Medical University on February 27, 2017 (IRB No. 2017PS035K).
Insights
MicroRNA-670 (miR-670) aggravates brain damage after stroke. Inhibiting miR-670 reduces neuronal apoptosis and neurological deficits, suggesting it
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Programmed cell death, or apoptosis, is critical in ischemia/reperfusion injury.
- MicroRNAs regulate molecular mechanisms in cerebral ischemia/reperfusion injury.
- The role and mechanism of miR-670 in cerebral ischemia/reperfusion injury are unclear.
Purpose of the Study:
- Investigate the role of miR-670 in cerebral ischemia/reperfusion injury.
- Elucidate the underlying molecular mechanism of miR-670 action.
- Explore miR-670 as a potential therapeutic target.
Main Methods:
- Established mouse models of transient middle artery occlusion.
- Utilized Neuro 2a cell models of oxygen-glucose deprivation and reoxygenation.
- Employed miR-670 antagomirs and agomirs to modulate miR-670 expression.
Main Results:
- miR-670 expression increased following ischemia/reperfusion injury.
- Inhibiting miR-670 reduced neuronal death and neurological deficits.
- Overexpressing miR-670 increased neuronal apoptosis.
- miR-670 promotes Yap degradation via phosphorylation, worsening injury.
Conclusions:
- MicroRNA-670 exacerbates cerebral ischemia/reperfusion injury via the Yap pathway.
- Targeting miR-670 may offer a therapeutic strategy for stroke.
- Yap pathway modulation by miR-670 is a key mechanism in brain injury.

